By Mrs. Shobanaraj M, Tutor- Dialysis Technology / Social Media Coordinator, Saveetha College of Allied Health Science, Saveetha Institute of Medical and Technical Sciences, Thandalam, Chennai, India
Breast cancer is a significant global health concern, and its prevalence has indeed been on the rise in recent times. In the context of breast cancer, cardiotoxicity is a concern primarily due to certain cancer treatments, particularly certain chemotherapy drugs and targeted therapies.
Chemotherapy-induced Cardiotoxicity is the most common one. To be more specific Anthracyclines and Trastuzumab in combination cause cardiotoxicity that may lead to a decrease in the heart’s ability to pump blood effectively and potentially cause conditions like cardiomyopathy and heart failure.
Oncologists closely monitor cardiac function during breast cancer treatment, especially when using potentially cardiotoxic agents. This monitoring may involve regular echocardiograms or other imaging studies to assess the heart’s pumping function.
Cardiovascular technologists play a vital role in cardiovascular health, and knowing cardiotoxicity and breast cancer allows them to provide more holistic patient care. They can better understand the potential cardiovascular implications of breast cancer treatments and contribute to comprehensive patient management.
On this view, Saveetha College of Allied Health Sciences Conducted a seminar for the students of Cardio Vascular Technology on the topic entitled ‘Cardiotoxicity Assessment In Breast Cancer. This session was conducted to provide an adequate view of the approach to the budding Cardiovascular Technologist while handling such cases in the future.
Awareness of cardiotoxicity associated with certain cancer treatments, including those used for breast cancer, is crucial for patient safety. Cardiovascular technologists can play a role in monitoring and identifying early signs of cardiotoxicity, contributing to the overall well-being of cancer patients undergoing treatment. Cardiovascular technologists often work as part of multidisciplinary healthcare teams.
Understanding the potential cardiovascular effects of breast cancer treatments allows them to collaborate more effectively with oncologists, cardiologists, and other healthcare professionals in providing integrated care for patients.
Cardiovascular technologists specialize in diagnostic procedures and monitoring cardiovascular health. Learning about cardiotoxicity and its impact on the heart enables them to better interpret diagnostic results, such as echocardiograms, and communicate effectively with other healthcare providers regarding a patient’s cardiovascular status during cancer treatment.
Educating Patients is an ideal component in which Cardiovascular technologists often interact directly with patients. Knowledge about cardiotoxicity associated with breast cancer treatments allows them to educate patients about potential cardiovascular risks, the importance of regular monitoring, and adherence to follow-up appointments.
Cardiovascular technologists can advocate for the cardiovascular health and well-being of breast cancer patients. This may involve collaborating with the healthcare team to ensure appropriate monitoring, advocating for necessary interventions, and promoting patient education on cardiovascular health.
In summary, integrating knowledge about cardiotoxicity and breast cancer into the education of Cardiovascular Technology students enhances their ability to provide comprehensive care, contribute to multidisciplinary healthcare teams, and adapt to evolving healthcare practices. It also positions them to be advocates for the cardiovascular health of patients undergoing breast cancer treatment.
Leave a Reply